EGFR and invasive breast carcinoma: Human epidermal growth factor receptor 2 (HER2), also known as receptor tyrosine-protein kinase ERBB2, belongs to the epidermal growth factor receptor (EGFR) family, and it is one of the most important oncogenes in invasive breast cancer.